Closing the Gap in Care in Seronegative Inflammatory Arthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Rheumatologists treating patients with seronegative arthritis will be randomized to treat their patients to a target or to treat their patients under their usual standard of care. All physicians will perform an initial chart audit. Following the initial chart audit, all physicians in the treat-to-target group will receive accredited educational training. Six months after the initial chart audit, all physicians will perform a repeat audit to see if patients are assessed more systematically and treated to a target of low disease state.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Peer to Peer Mentoring For Individuals With Early Inflammatory Arthritis: An Effectiveness Study (Pilot RCT)- Peer Mentoring Program

NCT01347359

Early Inflammatory Arthritis

COMPLETED NA

Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography

NCT01476956

Rheumatoid Arthritis

COMPLETED

Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology

NCT05116163

Systemic Lupus Erythematosus Rheumatoid Arthritis Inflammatory Arthritis +1 more

COMPLETED NA

Self-assessment Triage in Inflammatory Arthritis

NCT04956380

Inflammatory Arthritis

UNKNOWN NA

Improving Beliefs About Medication in Patients With Rheumatoid Arthritis

NCT00968266

Musculoskeletal Diseases Rheumatoid Arthritis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SpA PsA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No education or feedback

Rheumatologists randomized to this treatment arm receive no additional education or feedback about their systematic assessments of patients

Group Type NO_INTERVENTION

No interventions assigned to this group

Education and Feedback

Rheumatologists randomized to receive education and feedback participate in six web conferences designed to improve their systematic assessments of their patients, and are given feedback about their performances

Group Type EXPERIMENTAL

Education and Feedback

Intervention Type BEHAVIORAL

Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Education and Feedback

Rheumatologists are rated on how systematically they assess their patients, and receive six sessions of university accredited education about systematic assessments of patients with seronegative arthritis.

Intervention Type BEHAVIORAL